Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
Amneal Pharmaceuticals ended 2025 with strong financial results, exceeding management’s guidance in every key metric. With its sights set on continued growth in 2026, the company underscores its ongoing momentum in a competitive market.
20 hours ago
2 mins read